In today’s recent session, 0.57 million shares of the Oncolytics Biotech, Inc (NASDAQ:ONCY) have been traded, and its beta is 1.25. Most recently the company’s share price was $0.84, and it changed around $0.05 or 5.76% from the last close, which brings the market valuation of the company to $64.48M. ONCY at last check was trading at a discount to its 52-week high of $1.53, offering almost -82.14% off that amount. The share price’s 52-week low was $0.71, which indicates that the recent value has risen by an impressive 15.48% since then. We note from Oncolytics Biotech, Inc’s average daily trading volume that its 10-day average is 3.95 million shares, with the 3-month average coming to 1.04 million.
Oncolytics Biotech, Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.17. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 0 recommended ONCY as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Oncolytics Biotech, Inc is expected to report earnings per share of -0.13 for the current quarter.
Oncolytics Biotech, Inc (NASDAQ:ONCY) trade information
Instantly ONCY has been showing a green trend so far today with a performance of 5.76% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.8600 on recent trading dayincreased the stock’s daily price by 2.33%. The company’s shares are currently down -8.45% year-to-date, but still up 0.61% over the last five days. On the other hand, Oncolytics Biotech, Inc (NASDAQ:ONCY) is 8.51% up in the 30-day period. We can see from the shorts that 2.81 million shares have been sold at a short interest cover period of 3.51 day(s).
Oncolytics Biotech, Inc (ONCY) estimates and forecasts
Oncolytics Biotech, Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -18.78 percent over the past six months and at a 3.33% annual growth rate that is well below the industry average of 16.50%.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 18.01%.
ONCY Dividends
Oncolytics Biotech, Inc’s next quarterly earnings report is expected to be released in February.
Oncolytics Biotech, Inc (NASDAQ:ONCY)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.82% of Oncolytics Biotech, Inc shares, and 1.76% of them are in the hands of institutional investors. The stock currently has a share float of 1.83%. Oncolytics Biotech, Inc stock is held by 47.0 institutions, with INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 0.2637% of the shares, which is about 0.2 million shares worth $0.2 million.
SEEDS INVESTOR LLC, with 0.2524% or 0.19 million shares worth $0.19 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
The former held 41.94 shares worth $34816.0, making up 0.05% of all outstanding shares.
